Literature DB >> 28465627

Nutritional control of antibiotic production by Streptomyces platensis MA7327: importance of l-aspartic acid.

Maria Falzone1, Emmanuel Crespo1, Klarissa Jones1, Gulaba Khan1, Victoria L Korn1, Amreen Patel1, Mira Patel1, Krishnaben Patel1, Carrie Perkins1, Sana Siddiqui1, Drew Stenger1, Eileen Yu1, Michael Gelber1, Robert Scheffler1, Vasyl Nayda1, Ariela Ravin1, Ronica Komal1, Jeffrey D Rudolf2, Ben Shen2, Vincent Gullo1, Arnold L Demain1.   

Abstract

Streptomyces platensis MA7327 is a bacterium producing interesting antibiotics, which act by the novel mechanism of inhibiting fatty acid biosynthesis. The antibiotics produced by this actinomycete are platensimycin and platencin plus some minor related antibiotics. Platensimycin and platencin have activity against antibiotic-resistant bacteria such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus; they also lack toxicity in animal models. Platensimycin also has activity against diabetes in a mouse model. We have been interested in studying the effects of primary metabolites on production of these antibiotics in our chemically defined production medium. In the present work, we tested 32 primary metabolites for their effect. They included 20 amino acids, 7 vitamins and 5 nucleic acid derivatives. Of these, only l-aspartic acid showed stimulation of antibiotic production. We conclude that the stimulatory effect of aspartic acid is due to its role as a precursor involved in the biosynthesis of aspartate-4-semialdehyde, which is the starting point for the biosynthesis of the 3-amino-2,4-dihydroxy benzoic acid portion of the platensimycin molecule.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28465627      PMCID: PMC5642980          DOI: 10.1038/ja.2017.49

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  17 in total

Review 1.  Bioprospecting for antituberculosis leads from microbial metabolites.

Authors:  Elizabeth Jane Ashforth; Chengzhang Fu; Xiangyang Liu; Huanqin Dai; Fuhang Song; Hui Guo; Lixin Zhang
Journal:  Nat Prod Rep       Date:  2010-10-04       Impact factor: 13.423

2.  Biosynthetic studies of platensimycin.

Authors:  Kithsiri B Herath; Athula B Attygalle; Sheo B Singh
Journal:  J Am Chem Soc       Date:  2007-11-23       Impact factor: 15.419

3.  Antibiotic resistance-the need for global solutions.

Authors:  Ramanan Laxminarayan; Adriano Duse; Chand Wattal; Anita K M Zaidi; Heiman F L Wertheim; Nithima Sumpradit; Erika Vlieghe; Gabriel Levy Hara; Ian M Gould; Herman Goossens; Christina Greko; Anthony D So; Maryam Bigdeli; Göran Tomson; Will Woodhouse; Eva Ombaka; Arturo Quizhpe Peralta; Farah Naz Qamar; Fatima Mir; Sam Kariuki; Zulfiqar A Bhutta; Anthony Coates; Richard Bergstrom; Gerard D Wright; Eric D Brown; Otto Cars
Journal:  Lancet Infect Dis       Date:  2013-11-17       Impact factor: 25.071

Review 4.  Platensimycin and platencin: promising antibiotics for future application in human medicine.

Authors:  Evan Martens; Arnold L Demain
Journal:  J Antibiot (Tokyo)       Date:  2011-09-14       Impact factor: 2.649

5.  Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes.

Authors:  Margaret Wu; Sheo B Singh; Jun Wang; Christine C Chung; Gino Salituro; Bindhu V Karanam; Sang Ho Lee; Maryann Powles; Kenneth P Ellsworth; Michael E Lassman; Corey Miller; Robert W Myers; Michael R Tota; Bei B Zhang; Cai Li
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-09       Impact factor: 11.205

6.  Platensimycin is a selective FabF inhibitor with potent antibiotic properties.

Authors:  Jun Wang; Stephen M Soisson; Katherine Young; Wesley Shoop; Srinivas Kodali; Andrew Galgoci; Ronald Painter; Gopalakrishnan Parthasarathy; Yui S Tang; Richard Cummings; Sookhee Ha; Karen Dorso; Mary Motyl; Hiranthi Jayasuriya; John Ondeyka; Kithsiri Herath; Chaowei Zhang; Lorraine Hernandez; John Allocco; Angela Basilio; José R Tormo; Olga Genilloud; Francisca Vicente; Fernando Pelaez; Lawrence Colwell; Sang Ho Lee; Bruce Michael; Thomas Felcetto; Charles Gill; Lynn L Silver; Jeffery D Hermes; Ken Bartizal; John Barrett; Dennis Schmatz; Joseph W Becker; Doris Cully; Sheo B Singh
Journal:  Nature       Date:  2006-05-18       Impact factor: 49.962

7.  Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties.

Authors:  Jun Wang; Srinivas Kodali; Sang Ho Lee; Andrew Galgoci; Ronald Painter; Karen Dorso; Fred Racine; Mary Motyl; Lorraine Hernandez; Elizabeth Tinney; Steven L Colletti; Kithsiri Herath; Richard Cummings; Oscar Salazar; Ignacio González; Angela Basilio; Francisca Vicente; Olga Genilloud; Fernando Pelaez; Hiranthi Jayasuriya; Katherine Young; Doris F Cully; Sheo B Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-24       Impact factor: 11.205

8.  A nine-step total synthesis of (-)-platencin.

Authors:  Konrad Tiefenbacher; Johann Mulzer
Journal:  J Org Chem       Date:  2009-04-17       Impact factor: 4.354

9.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

Authors:  R Monina Klevens; Melissa A Morrison; Joelle Nadle; Susan Petit; Ken Gershman; Susan Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; Allen S Craig; Elizabeth R Zell; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; Scott K Fridkin
Journal:  JAMA       Date:  2007-10-17       Impact factor: 56.272

10.  Platensimycin activity against mycobacterial beta-ketoacyl-ACP synthases.

Authors:  Alistair K Brown; Rebecca C Taylor; Apoorva Bhatt; Klaus Fütterer; Gurdyal S Besra
Journal:  PLoS One       Date:  2009-07-17       Impact factor: 3.240

View more
  3 in total

1.  Bioprocessing strategies for cost-effective large-scale biogenic synthesis of nano-MgO from endophytic Streptomyces coelicolor strain E72 as an anti-multidrug-resistant pathogens agent.

Authors:  Shahira H El-Moslamy
Journal:  Sci Rep       Date:  2018-02-28       Impact factor: 4.379

2.  Revealing Genome-Based Biosynthetic Potential of Streptomyces sp. BR123 Isolated from Sunflower Rhizosphere with Broad Spectrum Antimicrobial Activity.

Authors:  Neelma Ashraf; Sana Zafar; Roman Makitrynskyy; Andreas Bechthold; Dieter Spiteller; Lijiang Song; Munir Ahmad Anwar; Andriy Luzhetskyy; Ali Nisar Khan; Kalsoom Akhtar; Shazia Khaliq
Journal:  Antibiotics (Basel)       Date:  2022-08-04

3.  Systematic optimization for production of the anti-MRSA antibiotics WAP-8294A in an engineered strain of Lysobacter enzymogenes.

Authors:  Xusheng Chen; Shanren Li; Lingjun Yu; Amanda Miller; Liangcheng Du
Journal:  Microb Biotechnol       Date:  2019-09-14       Impact factor: 5.813

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.